Biodistribution of extracellular vesicles following administration into animals: A systematic review

Abstract In recent years, attention has turned to examining the biodistribution of EVs in recipient animals to bridge between knowledge of EV function in vitro and in vivo. We undertook a systematic review of the literature to summarize the biodistribution of EVs following administration into animal...

Full description

Bibliographic Details
Main Authors: Matthew Kang, Vanessa Jordan, Cherie Blenkiron, Lawrence W. Chamley
Format: Article
Language:English
Published: Taylor & Francis Group 2021-06-01
Series:Journal of Extracellular Vesicles
Subjects:
Online Access:https://doi.org/10.1002/jev2.12085
id doaj-8d102dcf09444ed6841e3d3d9195fa55
record_format Article
spelling doaj-8d102dcf09444ed6841e3d3d9195fa552021-06-24T15:02:35ZengTaylor & Francis GroupJournal of Extracellular Vesicles2001-30782021-06-01108n/an/a10.1002/jev2.12085Biodistribution of extracellular vesicles following administration into animals: A systematic reviewMatthew Kang0Vanessa Jordan1Cherie Blenkiron2Lawrence W. Chamley3Department of Obstetrics and Gynaecology University of Auckland Auckland New ZealandDepartment of Obstetrics and Gynaecology University of Auckland Auckland New ZealandDepartment of Obstetrics and Gynaecology University of Auckland Auckland New ZealandDepartment of Obstetrics and Gynaecology University of Auckland Auckland New ZealandAbstract In recent years, attention has turned to examining the biodistribution of EVs in recipient animals to bridge between knowledge of EV function in vitro and in vivo. We undertook a systematic review of the literature to summarize the biodistribution of EVs following administration into animals. There were time‐dependent changes in the biodistribution of small‐EVs which were most abundant in the liver. Detection peaked in the liver and kidney in the first hour after administration, while distribution to the lungs and spleen peaked between 2–12 h. Large‐EVs were most abundant in the lungs with localization peaking in the first hour following administration and decreased between 2–12 h. In contrast, large‐EV localization to the liver increased as the levels in the lungs decreased. There was moderate to low localization of large‐EVs to the kidneys while localization to the spleen was typically low. Regardless of the origin or size of the EVs or the recipient species into which the EVs were administered, the biodistribution of the EVs was largely to the liver, lungs, kidneys, and spleen. There was extreme variability in the methodology between studies and we recommend that guidelines should be developed to promote standardization where possible of future EV biodistribution studies.https://doi.org/10.1002/jev2.12085apoptotic bodybiodistributionexosomeextracellular vesiclesmicroparticlemicrovesicle
collection DOAJ
language English
format Article
sources DOAJ
author Matthew Kang
Vanessa Jordan
Cherie Blenkiron
Lawrence W. Chamley
spellingShingle Matthew Kang
Vanessa Jordan
Cherie Blenkiron
Lawrence W. Chamley
Biodistribution of extracellular vesicles following administration into animals: A systematic review
Journal of Extracellular Vesicles
apoptotic body
biodistribution
exosome
extracellular vesicles
microparticle
microvesicle
author_facet Matthew Kang
Vanessa Jordan
Cherie Blenkiron
Lawrence W. Chamley
author_sort Matthew Kang
title Biodistribution of extracellular vesicles following administration into animals: A systematic review
title_short Biodistribution of extracellular vesicles following administration into animals: A systematic review
title_full Biodistribution of extracellular vesicles following administration into animals: A systematic review
title_fullStr Biodistribution of extracellular vesicles following administration into animals: A systematic review
title_full_unstemmed Biodistribution of extracellular vesicles following administration into animals: A systematic review
title_sort biodistribution of extracellular vesicles following administration into animals: a systematic review
publisher Taylor & Francis Group
series Journal of Extracellular Vesicles
issn 2001-3078
publishDate 2021-06-01
description Abstract In recent years, attention has turned to examining the biodistribution of EVs in recipient animals to bridge between knowledge of EV function in vitro and in vivo. We undertook a systematic review of the literature to summarize the biodistribution of EVs following administration into animals. There were time‐dependent changes in the biodistribution of small‐EVs which were most abundant in the liver. Detection peaked in the liver and kidney in the first hour after administration, while distribution to the lungs and spleen peaked between 2–12 h. Large‐EVs were most abundant in the lungs with localization peaking in the first hour following administration and decreased between 2–12 h. In contrast, large‐EV localization to the liver increased as the levels in the lungs decreased. There was moderate to low localization of large‐EVs to the kidneys while localization to the spleen was typically low. Regardless of the origin or size of the EVs or the recipient species into which the EVs were administered, the biodistribution of the EVs was largely to the liver, lungs, kidneys, and spleen. There was extreme variability in the methodology between studies and we recommend that guidelines should be developed to promote standardization where possible of future EV biodistribution studies.
topic apoptotic body
biodistribution
exosome
extracellular vesicles
microparticle
microvesicle
url https://doi.org/10.1002/jev2.12085
work_keys_str_mv AT matthewkang biodistributionofextracellularvesiclesfollowingadministrationintoanimalsasystematicreview
AT vanessajordan biodistributionofextracellularvesiclesfollowingadministrationintoanimalsasystematicreview
AT cherieblenkiron biodistributionofextracellularvesiclesfollowingadministrationintoanimalsasystematicreview
AT lawrencewchamley biodistributionofextracellularvesiclesfollowingadministrationintoanimalsasystematicreview
_version_ 1721361327987884032